Partnering with the US Government to Advance Neuromodulation

3:45 PM - 5:15 PM Friday, January 14

This session will present perspectives from representatives of government agencies that support or regulate research into the efficacy, safety, and mechanisms of new neuromodulation applications. NANS attendees will learn about how potential new treatments are studied for market approval, how research funders prioritize studies and what new opportunities are available, and in general, how to work with the federal government to advance new treatments.


Eugene Civillico, PhD

Michael B. Wolfson, PhD

David McMullen, MD

Matt McMahon

Kari Ashmont, PhD